Generics makers appeal pay-for-delay ban to Ninth Circuit

A group of generics manufacturers yesterday, December 2 asked the US Court of Appeals for the Ninth Circuit to reverse California’s ban on pay-for-delay deals.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

California outlaws pay-for-delay deals

9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

Americas

California mulls state generics brand

13 January 2020 California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.

Americas

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

25 February 2020 The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

More on this story

Americas

California outlaws pay-for-delay deals

9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

Americas

California mulls state generics brand

13 January 2020 California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.

Americas

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

25 February 2020 The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

More on this story

Americas

California outlaws pay-for-delay deals

9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

Americas

California mulls state generics brand

13 January 2020 California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.

Americas

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

25 February 2020 The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

More features

Fed Circ orders Teva to delist five patents from Orange Book

Sarepta wins $115M in patent dispute over muscular dystrophy drug

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York

Generics makers appeal pay-for-delay ban to Ninth Circuit

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features